Mural Oncology
Why Robinhood?
You can watch Mural Oncology and buy or sell other stocks, ETFs, and their options commission-free!About MURA
Mural Oncology Plc is a clinical-stage oncology company, which focuses on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. Its lead product candidate is the Nemvaleukin Alfa which is an interleukin-2 cytokine designed to capture and expand therapeutic benefits of high-dose recombinant human IL-2.
MURA Key Statistics
Stock Snapshot
With a market cap of 35.34M, Mural Oncology(MURA) trades at $2.04. The stock has a price-to-earnings ratio of -0.29.
On 2026-03-13, Mural Oncology(MURA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Mural Oncology(MURA) stock has reached 0.
Over the past 52 weeks, Mural Oncology(MURA) stock has traded between a high of $4.74 and a low of $0.95.
Over the past 52 weeks, Mural Oncology(MURA) stock has traded between a high of $4.74 and a low of $0.95.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.